Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PXMD

PXMD - PaxMedica, Inc. Stock Price, Fair Value and News

00
Market Closed

Price Targets

PXMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PXMD Price Action

Trailing 12 Months

-100%

PXMD RSI Chart

PXMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PXMD Valuation

PXMD Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

PXMD Fundamentals

PXMD Earnings

Earnings (TTM)

-13.5M

PXMD Profitability

Return on Equity

698.3%

Return on Assets

-1.6K%

PXMD Investor Care

About PaxMedica, Inc.

PXMD
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human African trypanosomiasis (HAT). It also develops PAX-102, an intranasal formulation of suramin for neurologic indications; and HAT-301 for the treatment of stage 1 East African HAT. The company has a research collaboration with PoloMar Health to investigate the use of emodin in a clinical program as a potential treatment for patients with autism spectrum disorder The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York.
 CEO
 WEBSITEpaxmedica.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES3

PaxMedica, Inc. Frequently Asked Questions

PXMD is the stock ticker symbol of PaxMedica, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jan 27 2026, market cap of PaxMedica, Inc. is 0. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PXMD's fair value in chart for subscribers.

The fair value guage provides a quick view whether PXMD is over valued or under valued. Whether PaxMedica, Inc. is cheap or expensive depends on the assumptions which impact PaxMedica, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PXMD.